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Introduction. Healthcare-associated infections (HAIs) present a major public health 
problem with an impact on morbidity, mortality and quality of life. On overage, up to 7% 
of patients in high-income countries and 10% in middle and low-income countries acquire 
at least one HAI. Deaths caused by HAIs account for about 10% of affected patients. At the 
national level data on the epidemiological situation and risk factors in HAIs are incom-
plete, against the background of underreporting, lack of active surveillance of HAIs, frag-
mented surveillance of antimicrobial resistance and antimicrobial use (AM) at the health 
facility level. 
The objective of the study was to highlight the problem of HAIs and AM use in acute care 
hospitals, identification of risk factors and raising awareness of the problem among 
health-care workers and decision makers by using active epidemiological surveillance. 
Material and methods. The methodology of the point prevalence survey of healthcare-
associated infections and antimicrobial use in acute care hospitals (PPS) was patient-
based, developed based on the European Centre for Disease Prevention and Control 
(ECDC) Protocol version 5.3/2016. The study was accomplished in 2018, on a sample of 
67 hospitals, 546 wards and 10594 patients. 
Data collection and validation were performed on paper at the health facility level, data 
analysis was accomplished using Helics.Win.Net software. The PPS study generated hos-
pital, ward and patient indicators, including the prevalence of HAIs and AM use relative 
to risk factors. 
Results. The prevalence of HAIs was 1.6%, with predominance of pneumonia (25%), sur-
gical site infections (16.1%), lower respiratory tract infections (14.9%), urinary tract in-
fections (11.3%). The highest prevalence of HAIs was recorded at the patients from inten-
sive care units – 20.0%, the patients with invasive medical devices (intubated – 32.1%, 
central vascular catheter – 22.8%, urinary catheter – 15.2%), in patients with NHSN sur-
gery (6.9%) and with severity of underlying illness (8.2%). In 72% HAIs were associated 
with the current admission, in patients with hospitalization period ≥15 days the preva-
lence of HAIs was 3.3% compared to 0.6% in those with a hospital stay of 1-3 days. The 
etiological confirmation of HAIs was reported only in 23,2% of cases, the causative agent 
being presented by Klebsiella spp. in 26%, Enterococcuss spp. – 18%, coagulase-negative 
Staphylococci – 14% and P. aeruginosa – 12%. Klebsiella spp. showed increased resistance 
to 3rd generation cephalosporins – 84.6% and to carbapenems – 46.2%. The prevalence 
of AM use was 42.7%, with an average of 1.3 antimicrobials administered to one patient. 
The most frequently used antimicrobials were the 3rd generation cephalosporins – 
34.5%, broad-spectrum penicillins – 12.9%, the 1st and 2nd generation of cephalosporins 
– respectively 10.6% and 8.2%. Antimicrobials were more frequently prescribed for treat-
ment (73.8%) and for surgical prophylaxis for more than one day – in 93.5%. 
Conclusions. Data on HAIs and AM use in hospitals, obtained for the first time by imple-
menting active surveillance based on the ECDC tool, are standardized and comparable at 
national and international level and allow the assessment of the situation in hospitals, 
obtaining evidence for infection prevention and control and AM stewardship programmes 
at local level, and arguing national policies. 
 
 
 
